Aradigm Corporation
3929 Point Eden Way
Hayward
California
94545
United States
Tel: 510-265-9000
Fax: 510-265-0277
Website: http://www.aradigm.com/
213 articles about Aradigm Corporation
-
Aradigm Corporation Announces First Closing Of Private Placement Offering Of $23 Million Senior Convertible Notes Due 2021
4/26/2016
-
Aradigm Corporation Prices Private Placement Of Senior Notes
4/22/2016
-
Aradigm Corporation Announces Fourth Quarter 2015 And Full Year Financial Results
3/15/2016
-
Aradigm Corporation To Present At The BIO CEO & Investor Conference 2016 On February 8
2/2/2016
-
Aradigm Corporation To Host Corporate Update Conference Call On January 6
1/5/2016
-
Aradigm Corporation Announces Third Quarter 2015 Financial Results
11/11/2015
-
Aradigm Corporation Completes Enrollment In The Second Phase III Study Of Pulmaquin In Non-Cystic Fibrosis Bronchiectasis (ORBIT-3)
10/13/2015
-
Aradigm Corporation Completes Enrollment In Phase III Study Of Pulmaquin In Non-Cystic Fibrosis Bronchiectasis (ORBIT-4)
9/22/2015
-
Aradigm Corporation Announces Second Quarter 2015 Financial Results
8/13/2015
-
Results From Pulmonary Non-Tuberculous Mycobacteria (PNTM) Study Using Aradigm Corporation’s Liposomal Ciprofloxacin To Be Presented At American Thoracic Society 2015 International Conference
5/12/2015
-
Aradigm Corporation Announces First Quarter 2015 Financial Results
5/11/2015
-
Aradigm Corporation Announces Appointment Of Dr. Robert A. Reed As Vice President, Regulatory (Chemistry, Manufacturing And Controls) And Quality
4/21/2015
-
Aradigm Corporation To Host Key Opinion Leader Breakfast And Webcast On April 23 In New York City
4/16/2015
-
Aradigm Corporation Announces Fourth Quarter 2014 And Full Year Financial Results
3/17/2015
-
Aradigm Corporation To Present At The Biotechnology Industry Organization (BIO) CEO & Investor Conference 2015 On February 10
2/4/2015
-
Aradigm Corporation Granted Key Composition Of Matter Patents For Pulmaquin In Europe And Australia
1/12/2015
-
Aradigm Corporation To Present At Biotech Showcase 2015 On January 14
1/8/2015
-
Aradigm Corporation To Present At The Stifel Healthcare Conference 2014
11/12/2014
-
Aradigm Corporation Announces Third Quarter 2014 Financial Results
11/7/2014
-
FDA Grants Fast Track Designation To Aradigm Corporation’s Pulmaquin For Non-Cystic Fibrosis Bronchiectasis
9/4/2014